Abbott, Alere, Roche, and Others Receive FDA Clearances in May

Jun 08, 2018

NEW YORK (360Dx) – Abbott, its subsidiary Alere, and Roche were among companies that received US Food and Drug Administration clearances in May for their in vitro diagnostic tests, according to the FDA website.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Breaking News

Featured White Papers

Advancing Patient Care and Aiding Diagnosis at the Point of Care

Molecular Tests Provide a Better Alternative to Stool Culture for GI Cases

Feb

26

Featured Webinar

A Cellular and Molecular Phenotyping Pipeline for Target Characterization in FFPE Biobank Samples

This webinar will demonstrate how a research team at the Firestone Institute for Respiratory Health at McMaster University developed a cellular and molecular phenotyping pipeline using archived samples of lung tissue derived from patients diagnosed with fibrotic interstitial lung disease.

Mar

19

Featured Webinar

One Test May Not Fit All: Evaluation of Point-of-Care Assays for Influenza Testing

In this webinar, Dr. Matthew Faron, a pathologist from the Medical College of Wisconsin, will share results of a comparison study of three rapid influenza assays.

Mar

20

Featured Webinar

A New Multiplex Syndromic System For Respiratory Diagnosis And Improved Patient Care

This webinar will discuss how a new multiplexed testing system can help physicians rapidly diagnose acute respiratory infections in the near-patient setting.

Mar

27

Featured Webinar

How One NGS Core Lab Reduced Sequencing Costs with a Novel Library Normalization Kit

Sequencing workflows require library quantification and normalization to ensure data quality and reduce cost.

Main menu